Patients treated with etoposide can develop acute myeloid leukemia (t-AML) [18] that had been demonstrated as attributing to TOP2B-mediated DNA breaks that disrupt mixed-lineage leukemia (MLL) and MLL-associated genes in human bone marrow cells [18]. This evidence concerns the gene KMT2A and acute myeloid leukemia.